<%
  import djerba.plugins.supplement.body.versioning as versions 
  import djerba.core.constants as core_constants
%>

<p>Whole Transcriptome libraries were prepared using the Illumina TruSeq Stranded Total RNA Library Prep Gold kit. 
  Paired-end sequencing was performed using the Illumina ${versions.ILLUMINA_VERSION} technology. 
  Reads were aligned using <a href=${versions.STAR_LINK}>STAR</a> (${versions.STAR_VERSION}) 
  and gene expression levels quantified using <a href=${versions.RSEM_LINK}>RSEM</a> (${versions.RSEM_VERSION}). 
  Fusions were called using <a href=${versions.STARFUSION_LINK}>STAR-Fusion</a> (${versions.STARFUSION_VERSION}) 
  and <a href=${versions.ARRIBA_LINK}>Arriba</a> (${versions.ARRIBA_VERSION}), followed by post processing with 
  <a href=${versions.MAVIS_LINK}>MAVIS</a> (${versions.MAVIS_VERSION}) and annotation using
  <a href=${versions.ONCOKB_LINK}>OncoKB</a> and the NCCN Compendium of biomarkers.

  The NCCN Compendium is a manually compiled list of somatic alterations for reporting in specific cancers. For Plasma Cell Myeloma (PCM) cases, we report t(4;14), t(14;16), t(11;14), and t(14;20) (<a href="${versions.NCCN_PCM_LINK}">NCCN Multiple Myeloma version ${versions.NCCN_PCM_VERSION}</a>). For ovarian cancer (OVARY), we report Homologous Recombination Deficiency (HRD) (<a href="${versions.NCCN_OVARIAN_LINK}">NCCN Ovarian Cancer version ${versions.NCCN_OVARIAN_VERSION}</a>).

</p>
